Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2005 / Cilt: 6 - Sayı: 1

Effects of vitamin K-3 on growth inhibition of rat glioma cell (C6) and human glioblastoma multiforme in vitro

K-3 vitamininin sıçan glioma (C6) ve insan glioblastoma multiforme hücre çoğalmasına in vitro etkileri

Pages
21–25
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that all these findings should contribute to other in vitro or in vivo studies on vitamin K-3 and glioblastoma multiforme cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Glioblastoma multiforme is characterized as a highly invasive and rapidly growing astrocytoma.
📊
Key Findings & Data:Previous studies have reported that vitamin K-3 inhibits cell growth of many types of malignant tumor cell lines.
💡
Conclusion & Impact:We believe that all these findings should contribute to other in vitro or in vivo studies on vitamin K-3 and glioblastoma multiforme cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Glioblastoma multiforme is characterized as a highly invasive and rapidly growing astrocytoma. Previous studies have reported that vitamin K-3 inhibits cell growth of many types of malignant tumor cell lines. In this study we aimed to investigate the possible inhibitory effect of vitamin K-3 on rat glioma (C6) and human glioblastoma multiforme cells. Method: The cells were exposed to 1, 10, 25, 50, 75 and 100 M of vitamin K-3 for 24 hours. Cell viability was estimated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. For statistical analysis one-wayANOVAtest and thenTukey's multiple comparison test were used.Results: The IC50 values of vitamin K-3 were calculated as 41 M for C6, and 24 M and 23 M for human glioblastoma multiforme cells.Conclusion: We have found that at low concentrations vitamin K-3 has an antiproliferative effect on both C6 and human glioma cells. We believe that all these findings should contribute to other in vitro or in vivo studies on vitamin K-3 and glioblastoma multiforme cells.

Özet

Amaç: Glioblastoma multiforme beyin dokusu içerisine hızla yayılan ve onu yıkıma uğratan, sinir sisteminde görülme sıklığı yüksek oldukça tehlikeli bir tümör çeşididir. K-3 vitamininin çeşitli kanser hücre dizileri üzerinde hücre çoğalmasını baskılayıcı etkisi olduğu bildirilmektedir. Çalışmamızda K-3 vitamininin, sıçan glioma (C6) ve insan glioblastoma multiforme hücrelerinin çoğalması üzerindeki baskılayıcı etkilerini karşılaştırarak elirlemeyi amaçladık. Yöntem: K-3 vitamininin 1, 10, 25, 50, 75 ve 100 M dozlarının hücre çoğalması üzerindeki etkilerini, besi ortamına ilave edildikten 24 saat sonra 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) yöntemi ile belirledik. Sonuçların istatistiksel değerlendirmesini tek yönlü varyans analizi ardından, Tukey'in çoklu karşılaştırma yöntemi ile yaptık.Bulgular: C6 ve insan glioblastoma multiforme hücre dizileri üzerinde K-3 vitamininin belirlenen dozlarının hücre yaşam oranı üzerindeki etkilerini belirledik. Hücrelerin çoğalmasını%50 oranında baskılayan doz olarak bilinen IC50 değerlerini C6 hücreleri için 41 M, glioblastoma multiforme hücreleri için 24 ve 23 M olarak belirledik.Sonuçlar: Çalışmamızda, K-3 vitamininin hem C6 hem de insan glioblastoma hücreleri üzerinde düşük dozlarda antiproliferatif etkisi olduğu sonucuna vardık. Bulgularımızın, K-3 vitamini ve glioblastoma multiforme üzerinde yapılacak başka in vitro ve in vivo çalışmalara ışık tutacağına inanmaktayız.

🔖

Cite This Article

ÖZTOPÇU, P., UYAR, R., KABADERE, S. (2022). Effects of vitamin K-3 on growth inhibition of rat glioma cell (C6) and human glioblastoma multiforme in vitro. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 6 - Sayı: 1, 21–25. https://ajindex.com/articles/429069

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Louis DN, Cavenee WK. Neoplasms of the central nervous system. In: DeVita, V.T., Hellman, S., and Rosenberg, S.A, eds; Cancer: principle and practice of oncology, 5 th ed. Philadelphia: Lippincott-Raven Publishers, 1997; 2013-2017. 2.Yaltkaya K, Balkan S, Oguz Y. Nöroloji Ders Kitabı, PalmeYayıncılık,Ankara, 1998; 292. 3.Bunin GG, Kuijten RR, Boesel PC. Materyal diet and risk of astrocytic glioma in children:report from the Childrens Cancer Group (United States and Canada). Cancer Cause Control 1994; 5 (2):177-187. 4.Mikkelsen T. Cytostatic agents in the management of malignant gliomas. Cancer Control:JMCC 1998; 5(2):150-162. 5.Salford LG, Siesjö P, Skagerberg G, Persson BRR, Larsson EM, Lindvall M, Visse E,Widegren B. Search for effective therapy against glioblastoma multiformeclinical immunisation with autologous glioma cells transduced with the human interferon- gene. International Congress Series 2002; 1247:211-220. 6.Raju TN. The Nobel chronicles. Lancet 1999; 353:761. 7.Suttie JW. The importance of menaquinones in human nutrition.Annu Rev Nutr 1995; 15:399-417. 8.Prasad KN, Prasad JE, Sakamoto A. Vitamin K (menadione) inhibits the growth of mammalian tumor cells in culture. Life Sci 1981; 13:1387-1392. 9.Ngo EO, Sun TP, Chang JY,Wang CC, ChiKW, Cheng AL, Nutter LM. Menadioneinduced DNAdamage in a human tumor cell line. Biochem Pharmacol 1991; 42(10):1961-1968. 10.Nutter LM, Cheng AL, Hung HL, Hsieh RK, Ngo EO, Liu TW. Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem Pharm. 1991; 41:1283-1292. 11.Durmaz R, Deliorman S, Isıksoy S, Uyar R, Erol K and Tel E: Antiproliferative properties of the Lazaroids U-83836E and U-74389G on glioma cells in vitro. Pathol Oncol Res 1999; 5(3):223-228. 12.Unterman TG, Glick RP, Waites GT, Bell SC. Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res 1991; 51:3030-3036. 13.Thomas DGT, Darling JL, Paul EA, Mott TJ, Godlee JN, Tobias JS, Capra LG, Collins CD, Mooney C, Bozek T, Finn GP, Arigbabu SO, Bullard DE, Shannon N, Freshney RI. Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Br J Cancer 1985; 51:525-532. 14.Mosmann T. Rapid calorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Methods 1983; 65:55-63. 15.Alley MC,